June 13, 2023
VIA EDGAR
Securities and Exchange Commission
100 F Street, N.E.
Washington, DC 20549
Re: | Bone Biologics Corp. | |
Registration Statement on Form S-1 (File No. 333-271558) |
Ladies and Gentlemen:
In connection with the above-captioned registration statement, and pursuant to Rule 461 under the Securities Act of 1933, as amended (the “Act”), EF Hutton, Division of Benchmark Investments, LLC, as representative of the underwriters, hereby joins in the request of the Company that the effective date of such registration statement be accelerated to 5:30 p.m. (New York time) on June 14, 2023, or as soon thereafter practicable.
In making this request, the undersigned acknowledges that the underwriters are aware of their obligations under the Act as they relate to the public offering of securities pursuant to the registration statement.
[signature page follows]
Very truly yours, | ||
EF HUTTON, DIVISION OF BENCHMARK INVESTMENTS, LLC | ||
By: | /s/ Sam Fleischman | |
Name: | Sam Fleischman | |
Title: | Supervisory Principal |